A clinical assessment of 'Fortral' suppositories in general practice.
D000328:Adult; D001416:Back Pain / Q000188:drug therapy; D001847:Bone Diseases / Q000188:drug therapy; D005194:Family Practice; D005221:Fatigue / Q000139:chemically induced; D005260:Female; D006801:Humans; D007592:Joint Diseases / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009135:Muscular Diseases / Q000188:drug therapy; D009325:Nausea / Q000139:chemically induced; D010423:Pentazocine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D012649:Self Concept; D013122:Spinal Diseases / Q000188:drug therapy; D013488:Suppositories; D013997:Time Factors; D014717:Vertigo / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D013488:Suppositories; D010423:Pentazocine